Clinical Trial Update: Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the efficacy and safety of Nidadd in hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Nidadd

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED